Mendelian-Randomization Study Reveals Causal Relationships Between Blood Metabolites and Psychiatric Disorders
Abstract
Background and hypothesis: Metabolic dysregulation has been widely observed in psychiatric disorders. However, the causal relationships between metabolites and psychiatric disorders remain largely unknown.
Study design: Here, we conducted bidirectional Mendelian randomization (MR) analyses to systematically investigate causal relationships between 8 psychiatric disorders (including attention deficit hyperactivity disorder (ADHD), anorexia nervosa (AN), anxiety, bipolar disorder (BIP), depression, posttraumatic stress disorder (PTSD), insomnia, and schizophrenia (SCZ)) and 1139 blood metabolites (including 823 metabolite levels and 316 metabolite ratios).
Study results: In forward MR, we identified 34, 21, 56, and 1 metabolites that are associated with BIP, SCZ, depression, and PTSD, respectively. Notably, several metabolites are associated with the risk of multiple psychiatric disorders. For instance, N2,N2-dimethylguanosine, 1,2-dipalmitoyl-gpc (16:0/16:0), and phosphatidylcholine acyl-alkyl C38:4 were negatively associated with the risk of SCZ and BIP. In reverse MR analyses, we explored the causal effects of psychiatric disorders on metabolites, and found that blood metabolites are also influenced by psychiatric disorders. For example, depression significantly affected 21 metabolite levels, including positively associated with 21-hydroxypregnenolone disulfate, and negatively associated with carotenoid.
Conclusions: Our findings not only uncover the causal relationships…
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.